AP2733A - Quinoline derivatives as antibacterial agents - Google Patents

Quinoline derivatives as antibacterial agents

Info

Publication number
AP2733A
AP2733A AP2008004300A AP2008004300A AP2733A AP 2733 A AP2733 A AP 2733A AP 2008004300 A AP2008004300 A AP 2008004300A AP 2008004300 A AP2008004300 A AP 2008004300A AP 2733 A AP2733 A AP 2733A
Authority
AP
ARIPO
Prior art keywords
antibacterial agents
quinoline derivatives
quinoline
derivatives
antibacterial
Prior art date
Application number
AP2008004300A
Other languages
English (en)
Inventor
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of AP2733A publication Critical patent/AP2733A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2008004300A 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents AP2733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05105769 2005-06-28

Publications (1)

Publication Number Publication Date
AP2733A true AP2733A (en) 2013-09-30

Family

ID=35445742

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004300A AP2733A (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents

Country Status (34)

Country Link
US (2) US20100204270A1 (xx)
EP (1) EP1898910B1 (xx)
JP (1) JP5193859B2 (xx)
KR (1) KR101423229B1 (xx)
CN (1) CN101252928B (xx)
AP (1) AP2733A (xx)
AR (1) AR057654A1 (xx)
AU (1) AU2006263884B2 (xx)
BR (1) BRPI0612534B8 (xx)
CA (1) CA2612623C (xx)
CY (1) CY1118515T1 (xx)
DK (1) DK1898910T3 (xx)
EA (1) EA014163B1 (xx)
ES (1) ES2606772T3 (xx)
HK (1) HK1120734A1 (xx)
HR (1) HRP20161704T1 (xx)
HU (1) HUE031268T2 (xx)
IL (1) IL188394A (xx)
JO (1) JO3270B1 (xx)
LT (1) LT1898910T (xx)
ME (1) ME02690B (xx)
MX (1) MX2008000082A (xx)
MY (1) MY151030A (xx)
NO (1) NO341283B1 (xx)
NZ (1) NZ564339A (xx)
PL (1) PL1898910T3 (xx)
PT (1) PT1898910T (xx)
RS (1) RS55408B1 (xx)
SG (1) SG166799A1 (xx)
SI (1) SI1898910T1 (xx)
TW (1) TWI392494B (xx)
UA (1) UA91549C2 (xx)
WO (1) WO2007000436A1 (xx)
ZA (1) ZA200711149B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790186B2 (en) 2009-07-21 2017-10-17 Trustees Of Dartmouth College Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection
US9617244B2 (en) 2012-04-27 2017-04-11 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
AU2013254674B2 (en) 2012-04-27 2017-02-02 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
CN105037497B (zh) * 2015-03-27 2018-06-26 中牧实业股份有限公司 一种恩拉霉素的提纯方法
WO2017035288A1 (en) * 2015-08-27 2017-03-02 Trustees Of Dartmouth College Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) * 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
BRPI0510414B1 (pt) * 2004-05-28 2022-04-05 Janssen Pharmaceutica N.V. Combinação e composição farmacêutica
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011436A1 (en) * 2002-07-25 2004-02-05 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDRIES, KOEN ET AL.: SCIENCE, vol. 307, 14 January 2005 (2005-01-14), pages 223-227, XP002358962, cited in the application, p. 223-224 *
DESAI P.K. ET AL.: "QUINOLINE DERIVATIVES AS ANTITUBERCULAR/ANTIBACTERIAL AGENTS", INDIAN JOURNAL OF CHEMISTRY, JODHPUR, IN, vol. 35B, no. 8, August 1996 (1996-08), p. 871-873, XP000944820, the whole document *
HELWIG, BURGHARD: "Moderne Arzneimittel", 1980, WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT, STUTTGART, XP002359316, page 395 *

Also Published As

Publication number Publication date
JP2008546825A (ja) 2008-12-25
CN101252928A (zh) 2008-08-27
SI1898910T1 (sl) 2017-01-31
PT1898910T (pt) 2016-11-16
BRPI0612534A8 (pt) 2017-12-26
HUE031268T2 (en) 2017-06-28
EP1898910B1 (en) 2016-09-28
BRPI0612534B1 (pt) 2020-04-22
BRPI0612534A2 (pt) 2010-11-23
CN101252928B (zh) 2012-05-23
AR057654A1 (es) 2007-12-12
RS55408B1 (sr) 2017-04-28
NZ564339A (en) 2011-02-25
EP1898910A1 (en) 2008-03-19
IL188394A (en) 2012-09-24
WO2007000436A1 (en) 2007-01-04
HK1120734A1 (en) 2009-04-09
SG166799A1 (en) 2010-12-29
TW200738237A (en) 2007-10-16
JP5193859B2 (ja) 2013-05-08
KR101423229B1 (ko) 2014-07-25
KR20080028460A (ko) 2008-03-31
LT1898910T (lt) 2017-01-10
US20130030017A1 (en) 2013-01-31
ZA200711149B (en) 2009-06-24
AU2006263884B2 (en) 2013-01-10
HRP20161704T1 (hr) 2017-02-10
IL188394A0 (en) 2008-08-07
MY151030A (en) 2014-03-31
EA014163B1 (ru) 2010-10-29
EA200800152A1 (ru) 2008-06-30
BRPI0612534B8 (pt) 2021-05-25
ME02690B (me) 2017-10-20
NO341283B1 (no) 2017-10-02
CY1118515T1 (el) 2017-07-12
US20100204270A1 (en) 2010-08-12
PL1898910T3 (pl) 2017-03-31
JO3270B1 (ar) 2018-09-16
CA2612623C (en) 2016-09-27
NO20080481L (no) 2008-02-29
UA91549C2 (ru) 2010-08-10
TWI392494B (zh) 2013-04-11
AU2006263884A1 (en) 2007-01-04
ES2606772T3 (es) 2017-03-27
CA2612623A1 (en) 2007-01-04
DK1898910T3 (en) 2017-01-09
MX2008000082A (es) 2008-03-24

Similar Documents

Publication Publication Date Title
IL189141A0 (en) Quinoline derivatives as antibacterial agents
AP2654A (en) Quinoline derivatives as antibacterial agents
IL187904A0 (en) Quinoline derivatives as antibacterial agents
HK1120732A1 (en) Quinoline derivatives as antibacterial agents
HK1124232A1 (en) Quinoline derivatives as antibacterial agents
HK1122730A1 (en) Quinoline derivatives as antibacterial agents
HK1120734A1 (en) Quinoline derivatives as antibacterial agents
ZA200710698B (en) Quinoline derivatives as antibacterial agents